Single Dose Comparability Study of New and Current Dupilumab Drug Products Subcutaneously Administered in Healthy Adults

NCT05976386 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Dupilumab (SAR231893)

Sponsor

Sanofi

Collaborators

[object Object]